Crosscope and KFBIO partners to lead digital transformation in pathology
Crosscope, a market leader in artificial intelligence software for digital pathology, has partnered with NINGBO KONFOONG BIOINFORMATION TECH CO.,LTD. (KFBIO), a maker of unique high-tech cutting-edge Whole slide imaging pathology scanners. Crosscope will ensure that a broad range of state-of-the-art Whole Slide Imaging Digital Pathology scanners is made available to the Indian market and that this cutting-edge technology is accessible to the pathology community in India and emerging markets, enabling digital transformation in pathology laboratories.
Today, cancer is India's most prevalent disease, accounting for more than 1.39 million cases per year. Pathologists are critical in the diagnosis and treatment of a wide variety of malignancies. The increasing number of cases has complicated pathologists' ability to diagnose the type of cancer. The digitization of the pathology work environment through the use of KFBIO scanners to assist pathologists in diagnosing histopathology slides more efficiently and accurately. Crosscope will provide KFBIO's state-of-the-art whole slide imaging scanners to India and emerging markets through this agreement. Today, digitization of clinical workflows is a critical enabler of seamless and rapid diagnosis for healthcare practitioners. Crosscope's goal is to enable change in histopathology by bringing the benefits of digital tools and technology to an existing analogue environment in the histopathology domain.
Crosscope's team will enable seamless availability of KFBIO Whole Slide Imaging scanners throughout the region with an integrated strategy to support, training, and hand-holding healthcare providers. "Pathology is on the verge of digital transformation, and Crosscope is committed to bridging gaps and ushering in a new era of individualised diagnoses by offering end-to-end digital pathology solutions. Crosscope is pleased to partner with KFBIO to offer their scanners alongside our cutting-edge AI software and collaboration platform, enabling our customers to automate Oncopathology. Pathology digitization is a critical area for the application of AI-based diagnostic algorithms to expedite and improve diagnosis, hence contributing to India's cancer burden reduction "Crosscope CEO Dr. Jayendra Shinde stated.
The entire slide Scanners for imaging digital pathology are an integral part of a full and sophisticated histopathology workflow. By combining this cutting-edge technique for digitising glass slides with high-resolution digital photos, a complete transformation of the histopathology workflow will be enabled. The broad range of capacities offered in KFBIO's entire slide imaging scanners ensures that digital pathology scanners are matched to the workload of the histopathology lab and healthcare provider. "Both KFBIO and Crosscope are committed to establishing a platform for digital pathology with the goal of accelerating the digital transformation of laboratories worldwide. With India's healthcare industry at an inflection point, our partnership demonstrates our commitment to advancing digital solutions that boost medical infrastructure for efficient cancer care. We are delighted to have discovered a partner in Crosscope that shares our commitment to revolutionising Digital Pathology without Boundaries "Mr. Kun Gui, Vice President of KFBIO, stated.